Article: Quark Biotech Inc. Receives Equity Investment From Taisho Pharmaceutical Co. Ltd.

Business Editors & Health/Medical Writers

BIOWIRE2K

CLEVELAND--(BW HealthWire)--Aug. 22, 2001

Quark Biotech Inc. (QBI), announced today that Taisho Pharmaceutical Co. Ltd. of Japan has made an equity investment in the Company.

The investment was made as part of QBI's Series F financing. Financial terms were not disclosed.

QBI and Taisho are currently collaborating on scientific research projects to discover the genes that cause kidney disease and to develop a therapeutic treatment for the cause of the disease, rather than just affecting the symptoms. QBI and Taisho have already completed initial feasibility studies and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!